Extracellular Vesicles (EVs) & Nanoparticles 2024: Diagnostics, Delivery, Therapeutics

Date: Wednesday, 3 April 2024 - Thursday, 4 April 2024
Location: Miami, Florida

Conference Chairs

Michael Graner
Professor, University of Colorado Anschutz School of Medicine

Mei He
Associate Professor, University of Florida

Keynote Speakers

Danilo Tagle
Director, Office of Special Initiatives, National Center for Advancing Translational Sciences at the NIH (NCATS)

Steve Soper
Foundation Distinguished Professor, Director, Center of BioModular Multi-Scale System for Precision Medicine, The University of Kansas

Dominique PV de Kleijn
Professor Experimental Vascular Surgery, Professor Netherlands Heart Institute, University Medical Center Utrecht, The Netherlands

Andrea Raymond
Associate Professor, Herbert Wertheim College of Medicine, Florida International University

Raymond Schiffelers
Professor of Nanomedicine, University Medical Center Utrecht

Tony Jun Huang
William Bevan Distinguished Professor of Mechanical Engineering and Materials Science, Duke University

Daniel Chiu
A. Bruce Montgomery Professor of Chemistry, University of Washington

Steven Stice
Co-Founder and Chief Scientific Officer, Aruna Bio; DW Brook Distinguished Professor and Director of the Regenerative Bioscience Center, Georgia Research Alliance Eminent Scholar, University of Georgia

Damien Pearse
Professor, Department of Neurological Surgery; The John M. and Jocelyn H.K. Watkins Distinguished Chair in Cell Therapies, University of Miami Miller School of Medicine

Overview

SelectBIO is delighted to welcome you to the Extracellular Vesicles 2024 Conference: Diagnostics, Delivery, Therapeutics.

This conference is being held April 3-4, 2024 right at the Miami International Airport.

SelectBIO is honored to welcome Professor Mei He, University of Florida as Conference Chairperson.

This conference brings together academic and industry participants for a 2-day deep dive into timely topics in the Extracellular Vesicles (EVs) field with emphasis on technologies for isolation and study of extracellular vesicles as well as the downstream studies in the EV field such as biomarker analysis, diagnostics and therapeutics development.

In addition to the biomarker and diagnostic potential of EVs, we explore at this conference the latest work and developments in EV-based Therapeutics and the Drug Delivery and Therapeutics Opportunities in the EV Field.

Presentations at this conference from academics as well as industry participants and the goal is 2-days of extensive scientific exchange as well as networking opportunities.

We welcome exhibitors and companies in the field to engage and participate at this conference and showcase their latest developments and offerings to the field.

Agenda Topics

Biomarker Content of Extracellular Vesicles and Role for Diagnostics Development (RNAs, Proteins, Lipids)
Disease Areas where EV-based Diagnostics Being Developed
Extracellular Vesicles (EVs): Therapeutic and Drug Delivery Potential
Single Extracellular Vesicle (EV) Analysis by Flow Cytometry
Technologies for Engineering EVs for Therapeutics, Drug Delivery Vehicles
Technologies for the Isolation, Characterization and Study of Extracellular Vesicles (EVs)-Exosomes

Sponsorship and Exhibition Opportunities

Jeff Fan, Exhibition Manager
jeff@selectbioconferences.com
+1-510-857-4865

Confirmed Speakers to date

Tom Anchordoquy, Professor, University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences
Heather Branscome, Senior Scientist, ATCC and Research Assistant, George Mason University
Lew Brown, Business Development, Spectradyne
Houjian Cai, Associate Professor, University of Georgia
Eun Ji Chung, Dr. Karl Jacob Jr. and Karl Jacob III Early Career Chair, Associate Professor of Biomedical Engineering, Chemical Engineering and Materials Science, Surgery, and Medicine, University of Southern California
Clayton Deighan, North American Sales and Applications Manager, NanoFCM
Marcin Jurga, Chief Scientific Officer, EXO Biologics SA
Fatah Kashanchi, Professor and Director of Research, Lab of Molecular Virology, George Mason University
Sukhbir Kaur, Staff Scientist, National Cancer Institute, National Institutes of Health
Sven Rudolf Kreutel, Chief Executive Officer, Particle Metrix GmbH and CEO, Particle Metrix Inc., USA
Fei Liu, Faculty of Medicine, Brigham and Women's Hospital
Devika Manickam, Associate Professor, Duquesne University
Amber Murray, Senior VP, Application, Exokeryx
Alex Shephard, Market Manager, Unchained Labs
Shawn Sternisha, Product Manager, Beckman Coulter Life Sciences
Giacomo Vacca, President & CEO, Kinetic River Corp
Johnny Zhuang, Product Application Scientist, EXODUS BIO

Corporate Sponsors	Media Sponsors	Official Journal Partner	Networking

Add to Calendar ▼2024-04-03 00:00:002024-04-04 00:00:00Europe/LondonExtracellular Vesicles (EVs) and Nanoparticles 2024: Diagnostics, Delivery, TherapeuticsExtracellular Vesicles (EVs) and Nanoparticles 2024: Diagnostics, Delivery, Therapeutics in Miami, FloridaMiami, FloridaSELECTBIOenquiries@selectbiosciences.com

Corporate Sponsors